Built to Scale: How science and AI are powering the fight against counterfeit drugs – with Monika Štěpánová

How do you turn a scientific idea into a product that can save lives?

In this Built to Scale fireside chat, we’ll talk with Monika Štěpánová, CEO of Lightly Technologies, about their journey from research to real-world impact — and how they’re using science and AI to help people trust the medicines they take.

At the heart of their work is Catcher — a small, field-ready device that quickly verifies if a drug is genuine. Built on their patented UV-Fingerprint technology, it gives reliable results in minutes — without a lab, without experts, and without delays.

Built for simplicity. Designed for impact.

This event is also about bringing together a community of hardware startup founders, VC funds, and corporates who share an interest in turning great prototypes into sustainable businesses. Whether you’re building, investing, or partnering, we hope these conversations will inspire collaboration and spark new ideas.

If you’re curious about hardware development, product development, entrepreneurship, or simply the human side of building something from scratch, you’ll enjoy this story.

Evening Agenda

• 18:00 – Arrival
• 18:30 – Introduction to Built to Scale series
• 18:45 – Fireside chat & Q&A with Monika Štěpánová
• 20:00 – Networking & refreshments

This Built to Scale event is organised by Make More, in cooperation with PrusaLab and Uppersky.